Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

被引:245
作者
Ghivizzani, SC
Lechman, ER
Kang, R
Tio, C
Kolls, J
Evans, CH
Robbins, PD
机构
[1] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA
[3] Louisiana State Univ, Sch Med, Dept Pulm Med, New Orleans, LA 70112 USA
关键词
D O I
10.1073/pnas.95.8.4613
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Adenoviral vectors were used to deliver genes encoding a soluble interleukin 1 (IL-1)-type I receptor-IgG fusion protein and/or a soluble type I tumor necrosis factor alpha (TNF alpha) receptor-IgG fusion protein directly to the knees of rabbits with antigen-induced arthritis. When tested individually, knees receiving the soluble IL-1 receptor had significantly reduced cartilage matrix degradation and white blood cell infiltration into the joint space. Delivery of the soluble TNF alpha receptor was less effective, having only a moderate effect on white blood cell infiltration and no effect on cartilage breakdown. When both soluble receptors were used together, there was a greater inhibition of white blood cell infiltration and cartilage breakdown with a considerable reduction of synovitis. Interestingly, anti-arthritic effects were also seen in contralateral control knees receiving only a marker gene, suggesting that sustained local inhibition of disease activity in one joint mag confer an anti-arthritic effect on other joints. These results suggest that local intra-articular gene transfer could be used to treat systemic polyarticular arthritides.
引用
收藏
页码:4613 / 4618
页数:6
相关论文
共 36 条
  • [1] AREND WP, 1994, J IMMUNOL, V153, P4766
  • [2] INHIBITION OF THE PRODUCTION AND EFFECTS OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA IN RHEUMATOID-ARTHRITIS
    AREND, WP
    DAYER, JM
    [J]. ARTHRITIS AND RHEUMATISM, 1995, 38 (02): : 151 - 160
  • [3] INTERLEUKIN-1 RECEPTOR ANTAGONIST
    AREND, WP
    [J]. ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 : 167 - 227
  • [4] FIREFLY LUCIFERASE GENE - STRUCTURE AND EXPRESSION IN MAMMALIAN-CELLS
    DEWET, JR
    WOOD, KV
    DELUCA, M
    HELINSKI, DR
    SUBRAMANI, S
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (02) : 725 - 737
  • [5] EDWARDS JCW, 1988, BRIT J EXP PATHOL, V69, P739
  • [6] RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS
    ELLIOTT, MJ
    MAINI, RN
    FELDMANN, M
    KALDEN, JR
    ANTONI, C
    SMOLEN, JS
    LEEB, B
    BREEDVELD, FC
    MACFARLANE, JD
    BIJL, H
    WOODY, JN
    [J]. LANCET, 1994, 344 (8930) : 1105 - 1110
  • [7] Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis
    Evans, CH
    Mankin, HJ
    Ferguson, AB
    Robbins, PD
    Ghivizzani, SC
    Herndon, JH
    Kang, R
    Tomaino, MM
    Wright, TM
    [J]. HUMAN GENE THERAPY, 1996, 7 (10) : 1261 - 1280
  • [8] IMPROVED QUANTITATION AND DISCRIMINATION OF SULFATED GLYCOSAMINOGLYCANS BY USE OF DIMETHYLMETHYLENE BLUE
    FARNDALE, RW
    BUTTLE, DJ
    BARRETT, AJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 883 (02) : 173 - 177
  • [9] Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis
    Feldmann, M
    Elliott, MJ
    Woody, JN
    Maini, RN
    [J]. ADVANCES IN IMMUNOLOGY, VOL 64, 1997, 64 : 283 - 350
  • [10] ROLE OF SUBSTANCE-P IN INFLAMMATORY ARTHRITIS
    GARRETT, NE
    MAPP, PI
    CRUWYS, SC
    KIDD, BL
    BLAKE, DR
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (08) : 1014 - 1018